Sawai Pharmaceutical Achieves Double Digit Growth In Sales And Profits
This article was originally published in PharmAsia News
Executive Summary
Japan's largest generic drug maker Sawai increased sales by 16.4 percent and net profit by 32.8 percent in the third quarter, the company reported Feb. 9. Group sales grew to ¥33.41 billion and net profit increased to ¥2.09 billion. Saiwai cited a prescription form change in April 2008 and expanding generics use among dispensing pharmacies. The company also noted that sales to hospitals using diagnostic procedure combined payment systems have increased by 19.6 percent and net profit increased by 32.3 percent, both are record setting numbers for the company. Looking forward, the company looks to have a full year results that overtake last year's. (Click here for more - Japanese language